Investments, Funding & Disinvestment

AIGP Health designed Anzu to help clinicians access relevant patient information and clinical context during consultations.

The meeting brought together leaders and partners from both regions to discuss how country led priorities, stronger regional capacity and predictable financing can strengthen health systems and improve preparedness for future health emergencies.

Shanghai-based Raas disclosed the proposed acquisition in a financial filing, stating that it plans to acquire a 100% stake in Boehringer Ingelheim Biopharmaceuticals in China.

The European Union has mobilised €500 million (US$586 million) in emergency aid, vaccines, treatment and health security support for the Great Lakes and Uganda region.

The agreement brings together BoomRay’s expertise in radioligand therapy development and Novartis’ global capabilities in radiopharmaceutical research and commercialisation.

In its new publication, WHO Guidelines on Expanding Contraceptive Options, WHO provides countries with evidence-based recommendations to broaden access to contraceptive methods and offer more flexibility in how people use them.

The collaboration will assess selected targets for several therapeutic approaches, including antibody-drug conjugates (ADCs), multispecific antibodies and T cell engagers (TcEs).

The facility can produce starting materials, drug substances and drug products using customised processes as well as technology transferred from established manufacturing platforms.

The project will cover Cameroon, Chad, Mali, Niger and Nigeria, combining water, sanitation and hygiene (WASH) interventions with disease surveillance and medical support.

The new equipment will support a range of academic and institutional activities at the school. These include data analysis, research, lectures, seminars and virtual engagements.